LVL MEDICAL : Turnover on 30 June 2008

TURNOVER ON 30 JUNE 2008 :
GROWTH CONTINUES TO ACCELERATE IN THE THIRD QUARTER !

Turnover in M €	3rd quarter			First 9 months
	2008	2007	Variation	2008	2007	Variation
France	20.1	17.7	13.6%	58.6	52.1	12.5%
Germany	8.7	6.1	41.9%	25.5	17.9	42.8%
Group	28.8	23.8	20.9%	84.1	70.0	20.2%

In accordance with its determination to expand its market shares in France and Germany, the Group recorded accelerated growth in the third quarter with a 20.9% increase in consolidated turnover bringing it up to € 28.8M and growth over 9 months which exceeded forecasts by 20.2% (turnover of € 84.1M on 30 June 2008).

• In France, strengthening of our positions in strategic activities : + 24.5%
  in pni in the 3rd quarter

LVL Médical recorded turnover of €20.1M in the 3rd quarter, up 13.6% compared to the previous financial period.
This strong upward momentum was driven by sustained development in the Group’s strategic activities, in particular Perfusion, Nutrition and Insulin therapy (PNI) where LVL Médical strengthened its positions to achieve a quarterly turnover of €6.7M. This accelerated growth was particularly remarkable in insulin therapy for which the Group recorded a 31.4% increase in Q3 turnover compared to N-1.
The Group is also continuing to take over market shares in the respiratory sector which recorded 3rd quarter turnover of €13.1M, up 9.2% increase compared to the previous financial period.
During the first 9 months of the financial period turnover rose to €58.6M in France, up 12.5% compared to the previous financial period.

• In germany, very strong growth continued : + 42.8% during the first 9 months of the financial period

LVL Médical strengthened its position as leader in the German market for home-based medical care where it recorded a very strong increase in 3rd quarter turnover (+41.9%) which rose to €8.7M.
During the first 9 months of the financial period, turnover rose to €25.5M in Germany, up 42.8% compared to the previous financial period.
With comparable scope, growth in its German structures was 22.5%.
This level of performance is fully in line with the Management’s determination to see its German activities make an increasingly significant contribution to the Group’s consolidated turnover.

• Trends…

LVL Médical recalls that in France, unlike last year, the tariffs applicable in respiratory assistance were not reviewed in July 2008.
The Group also confirms improved profitability during the second half-year in France and Germany.
It can therefore confirm accelerated growth and improved result for the 2007-2008 financial period.

• Next announcement

LVL Médical will publish its annual turnover for the financial period closed on 30 September 2008 on 28 October after market.

Founded in 1989, LVL Médical Groupe has become, over the years, a leader in the medical service fields of respiratory assistance, perfusion, nutrition, insulin therapy and home-based medical care in France.
In Germany the Group is the leader in the provision of home-based nursing care and intensive care services and in dedicated structures.

LVL Médical Groupe
Communication Department
Phone : + 33 (0)4 26 68 68 68
actionnaires@lvl-medical.fr

Euronext Compartiment B Paris
ISIN FR0000054686
Reuters LVLM.PA
Bloomberg LVL
www.lvl-medical.com